Jagannadha Avasarala

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

CNS spectrums

British journal of clinical pharmacology

The Journal of rheumatology

Neurology

U of KY Medical Center

Washington University in Saint Louis (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

U of KY Medical Center Dec 02 2018

United States

Professor of Neurology, Director of Neuroimmunology and MS Section :: Neurology

Greenville Health System Aug 06 2014

United States

Consultant Neurologist and Neuroimmunologist :: Medicine

Education History

Washington University in Saint Louis May 01 2000 - Mar 01 2003

United States

MSC :: Neurology

Nagoya University Jan 01 1987 - Mar 01 1992

Japan

PHD :: ENT

Kakatiya Medical College Jun 01 1982 - May 03 1985

India

MSC :: ENT

Publications

Jagannadha Avasarala
Reader Response: Apathy After Stroke: Incidence, Symptom Trajectory, and Impact on Quality of Life and Disability. Neurology 103 (8) (2024)
Jagannadha Avasarala, Saurav Das, Suresh Keshavamurthy
Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant Cell Arteritis: Blindness Prevention on a Global Scale. The Journal of rheumatology (2024)
Jagannadha Avasarala
Does dosing frequency of anti-CD20 therapies blunt vaccine responses and increase COVID-19 susceptibility in patients with multiple sclerosis? British journal of clinical pharmacology (2024)
Jagannadha Avasarala, Phenu Zachariah
Unmasking Disparities: The Challenge of Diversity, Equity, and Inclusion in Press Ganey Surveys. CNS spectrums (2023)
Jagannadha Avasarala, Christopher J McLouth, Luther C Pettigrew, Sally Mathias, Sharoon Qaiser, Phenu Zachariah
VAERS-reported new-onset seizures following use of COVID-19 vaccinations as compared to influenza vaccinations. British journal of clinical pharmacology 88 (11) (2022)
Jagannadha Avasarala, Phenu Zachariah, Breck Turner
Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: when will we achieve parity? CNS spectrums (2021)
Jagannadha Avasarala, Brent S Sokola, Selina Mullins
Eculizumab package insert recommendations for meningococcal vaccinations: call for clarity and a targeted approach for use of the drug in neuromyelitis optica spectrum disorder. CNS spectrums 26 (3) (2019)
Jagannadha Avasarala
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients. CNS spectrums 24 (3) (2019)
Jagannadha Avasarala, Fawad Yousuf
Radiologically isolated syndrome is antiquated amidst evolving McDonald criteria for multiple sclerosis. CNS spectrums 26 (4) (2019)
Jagannadha Avasarala
Standardization of MRI data and disability quantification in the post-EPIC era. CNS spectrums 23 (1) (2017)
Jagannadha Avasarala, Keith Wesley
Optimization of acute stroke care in the emergency department: a call for better utilization of healthcare resources amid growing shortage of neurologists in the United States. CNS spectrums 23 (4) (2017)

Jagannadha Avasarala.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jagannadha Avasarala